Modifications to the "classical" autologous hematopoietic stem cell transplantation in multiple sclerosis: A less toxic approach is feasible and improves the neurological condition. A Mexican perspective

Authors
Category Primary study
JournalBiology of Blood and Marrow Transplantation
Year 2018
This article has no abstract
Epistemonikos ID: f983c58971373f3f2ac7a4fd889e94ced324e414
First added on: Feb 09, 2025